1. Home
  2. NVOS vs CVKD Comparison

NVOS vs CVKD Comparison

Compare NVOS & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVOS
  • CVKD
  • Stock Information
  • Founded
  • NVOS 2000
  • CVKD 2022
  • Country
  • NVOS United States
  • CVKD United States
  • Employees
  • NVOS N/A
  • CVKD N/A
  • Industry
  • NVOS Assisted Living Services
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • NVOS Health Care
  • CVKD Health Care
  • Exchange
  • NVOS Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • NVOS 9.9M
  • CVKD 8.2M
  • IPO Year
  • NVOS 2017
  • CVKD 2023
  • Fundamental
  • Price
  • NVOS $0.64
  • CVKD $0.46
  • Analyst Decision
  • NVOS
  • CVKD Strong Buy
  • Analyst Count
  • NVOS 0
  • CVKD 2
  • Target Price
  • NVOS N/A
  • CVKD $3.50
  • AVG Volume (30 Days)
  • NVOS 2.0M
  • CVKD 70.5K
  • Earning Date
  • NVOS 07-19-2024
  • CVKD 08-12-2024
  • Dividend Yield
  • NVOS N/A
  • CVKD N/A
  • EPS Growth
  • NVOS N/A
  • CVKD N/A
  • EPS
  • NVOS N/A
  • CVKD N/A
  • Revenue
  • NVOS $13,516,958.00
  • CVKD N/A
  • Revenue This Year
  • NVOS N/A
  • CVKD N/A
  • Revenue Next Year
  • NVOS N/A
  • CVKD N/A
  • P/E Ratio
  • NVOS N/A
  • CVKD N/A
  • Revenue Growth
  • NVOS 1102.98
  • CVKD N/A
  • 52 Week Low
  • NVOS $0.42
  • CVKD $0.36
  • 52 Week High
  • NVOS $5.38
  • CVKD $2.17
  • Technical
  • Relative Strength Index (RSI)
  • NVOS 47.46
  • CVKD 49.44
  • Support Level
  • NVOS $0.60
  • CVKD $0.43
  • Resistance Level
  • NVOS $0.74
  • CVKD $0.47
  • Average True Range (ATR)
  • NVOS 0.08
  • CVKD 0.02
  • MACD
  • NVOS 0.01
  • CVKD -0.00
  • Stochastic Oscillator
  • NVOS 58.54
  • CVKD 43.86

About NVOS Novo Integrated Sciences Inc.

Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

Share on Social Networks: